Intranasal immunization with autolysin (LytA) in mice model induced protection against five prevalent Streptococcus pneumoniae serotypes in China

Immunologic Research

Volumn 51, Issue 1, 2011, Pages 108-115

  Yuan, Zhu Qing ^a,b   Lv, Zhi Yue ^a   Gan, Hui Quan ^a   Xian, Mo ^a   Zhang, Kou Xing ^a   Mai, Jing Ying ^b   Yu, Xin Bing ^a   Wu, Zhong Dao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Intranasal immunization; LytA; Mice model; Prevalent serotypes; Streptococcus pneumoniae

Indexed keywords

AUTOLYSIN; BACTERIUM ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; SINGLE DRUG DOSE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHINA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, SYNTHETIC;

EID: 80053564864     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8234-x     Document Type: Article

References (17)

1. JC Butler ED Shapiro GM Carlone 1999 Pneumococcal vaccines: history, current status, and future directions Am J Med 107 69S 76S 10451012 10.1016/S0002-9343(99)00105-9 1:STN:280:DyaK1MznvVahsw%3D%3D (Pubitemid 29372764)
2. A Kadioglu PW Andrew 2004 The innate immune response to pneumococcal lung infection: the untold story Trends Immunol 25 143 149 15036042 10.1016/j.it.2003.12.006 1:CAS:528:DC%2BD2cXhsFWjur0%3D (Pubitemid 38249488)
3. E Swiatlo D Ware 2003 Novel vaccine strategies with protein antigens of Streptococcus pneumoniae FEMS Immunol Med Microbiol 38 1 7 12900048 10.1016/S0928-8244(03)00146-9 1:CAS:528:DC%2BD3sXlvFyjurY%3D (Pubitemid 37297436)
4. C Fernandez-Tornero E Garcia R Lopez G Gimenez-Gallego A Romero 2002 Two new crystal forms of the choline-binding domain of the major pneumococcal autolysin: insights into the dynamics of the active homodimer J Mol Biol 32 163 173 10.1016/S0022-2836(02)00596-X (Pubitemid 34948477)
5. D Bogaert PW Hermans PV Adrian HC Rumke R de Groot 2004 Pneumococcal vaccines: an update on current strategies Vaccine 22 2209 2220 15149779 10.1016/j.vaccine.2003.11.038 1:CAS:528:DC%2BD2cXktV2ltr8%3D (Pubitemid 38626060)
6. MJ Jedrzejas 2001 Pneumococcal virulence factors: structure and function Microbiol Mol Biol Rev 65 187 207 11381099 10.1128/MMBR.65.2.187-207.2001 1:CAS:528:DC%2BD3MXkvVKmu7g%3D (Pubitemid 32538177)
7. R Palaniappan S Singh UP Singh SK Sakthivel EW Ades DE Briles, et al. 2005 Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage Infect Immun 73 1006 1013 15664944 10.1128/IAI.73.2.1006-1013.2005 1:CAS:528:DC%2BD2MXhtVWgsrk%3D (Pubitemid 40165761)
8. AM van Rossum ES Lysenko JN Weiser 2005 Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model Infect Immun 73 7718 7726 16239576 10.1128/IAI.73.11.7718-7726.2005 (Pubitemid 41587678)
9. MM Levine 2003 Can needle-free administration of vaccines become the norm in global immunization? Nat Med 9 99 103 12514720 10.1038/nm0103-99 1:CAS:528:DC%2BD3sXivF2g (Pubitemid 36098268)
10. MR Neutra PA Kozlowski 2006 Mucosal vaccines: the promise and the challenge Nat Rev Immunol 6 148 158 16491139 10.1038/nri1777 1:CAS:528:DC%2BD28XhsFeqtbg%3D (Pubitemid 43361590)
11. GM Zhao S Black H Shinefield CQ Wang YH Zhang YZ Lin, et al. 2003 Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China Pediatr Infect Dis J 22 739 742 12913778 10.1097/01.inf.0000078373.54515.40 1:CAS:528:DC%2BD2cXksF2gt7Y%3D (Pubitemid 36999654)
12. DE Briles MJ Crain BM Gray C Forman J Yother 1992 Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae Infect Immun 60 111 116 1729176 1:CAS:528: DyaK38Xht1GqsL0%3D
13. MJ McCluskie HL Davis 1999 CpG DNA as mucosal adjuvant Vaccine 18 231 237 10506647 10.1016/S0264-410X(99)00194-2 1:CAS:528:DyaK1MXnsVegtbw%3D (Pubitemid 29443996)
14. DT O'Hagan ML MacKichan M Singh 2001 Recent developments in adjuvants for vaccines against infectious diseases Biomol Eng 18 69 85 11566599 10.1016/S1389-0344(01)00101-0 (Pubitemid 32889607)
15. JD Thompson DG Higgins TJ Gibson 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res 22 4673 4680 7984417 10.1093/nar/22.22.4673 1:CAS:528: DyaK2MXitlSgu74%3D (Pubitemid 24354800)
16. P Brandtzaeg 2003 Role of secretory antibodies in the defence against infections Int J Med Microbiol 293 3 15 12755363 10.1078/1438-4221-00241 1:CAS:528:DC%2BD3sXkvFGlurk%3D (Pubitemid 36534594)
17. P Romero R Lopez E Garcia 2007 Key role of amino acid residues in the dimerization and catalytic activation of the autolysin LytA, an important virulence factor in Streptococcus pneumoniae J Biol Chem 282 17729 17737 17439951 10.1074/jbc.M611795200 1:CAS:528:DC%2BD2sXmt1ers7g%3D (Pubitemid 47100289)